Physician profile
Kenneth Murphy
NPI 1346232980
$1,265.56
in general payments reported to CMS, 2019-2025
17 companies · $15.70 in 2025
The $15.70 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $447 · 2022: $361 · 2023: $407 · 2024: $34.66 · 2025: $15.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $340.29 | 2021-2023 | |
| Atricure, INC. | $186.48 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $91.48 | 2021-2023 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.29 | 2021-2023 | Lifevest |
| Abbott Laboratories | $78.47 | 2023-2025 | Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $75.11 | 2021-2023 | Farxiga |
| Boston Scientific Corporation | $69.65 | 2021-2023 | Watchman Access System |
| Cvrx, INC. | $57.45 | 2023-2024 | Barostim Neo System |
| Daiichi Sankyo INC. | $46.44 | 2021-2022 | |
| Amgen INC. | $39.21 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.94 | 2021-2022 | |
| Pfizer INC. | $37.20 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.69 | 2022-2023 | Verquvo |
| Medtronic, INC. | $33.42 | 2022 | |
| Alnylam Pharmaceuticals INC. | $23.71 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.82 | 2021 | |
| Astellas Pharma US INC | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.